Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18367 | 554 | 28.8 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
54 | 3 | ASTHMA//RESPIRATORY SYSTEM//ALLERGY | 90590 |
112 | 2 | ASTHMA//EOSINOPHILS//ALLERGY | 25091 |
18367 | 1 | DOXOFYLLINE//1 METHYL 3 PROPYL 7 BUTYLXANTHINE//7 THEOPHYLLINE ACETIC ACID | 554 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DOXOFYLLINE | authKW | 432104 | 3% | 56% | 14 |
2 | 1 METHYL 3 PROPYL 7 BUTYLXANTHINE | authKW | 110234 | 0% | 100% | 2 |
3 | 7 THEOPHYLLINE ACETIC ACID | authKW | 110234 | 0% | 100% | 2 |
4 | INFLAMMATORY CELL INFLUX | authKW | 110234 | 0% | 100% | 2 |
5 | ALKYLXANTHINE | authKW | 99208 | 1% | 60% | 3 |
6 | ENPROFYLLINE | authKW | 58785 | 1% | 27% | 4 |
7 | 0 CENTER DOT 9 SODIUM CHLORIDE INJECTION | authKW | 55117 | 0% | 100% | 1 |
8 | 1 3 8 TRISUBSTITUTED PURINE 2 6 DIONES | authKW | 55117 | 0% | 100% | 1 |
9 | 1 METHYL 3 PROPYL 7 BUTYLXATHINE | authKW | 55117 | 0% | 100% | 1 |
10 | 1 THEOBROMINE ACETIC ACID | authKW | 55117 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 4893 | 55% | 0% | 302 |
2 | Allergy | 2520 | 10% | 0% | 56 |
3 | Respiratory System | 2013 | 16% | 0% | 89 |
4 | Immunology | 314 | 13% | 0% | 72 |
5 | Chemistry, Medicinal | 269 | 7% | 0% | 40 |
6 | Toxicology | 56 | 4% | 0% | 21 |
7 | Medicine, Research & Experimental | 34 | 4% | 0% | 23 |
8 | Chemistry, Multidisciplinary | 21 | 7% | 0% | 40 |
9 | Physiology | 19 | 3% | 0% | 17 |
10 | Critical Care Medicine | 17 | 1% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARDIOL NEPHROL PNEUMOL | 55117 | 0% | 100% | 1 |
2 | HEISLER MONTREAL CHEST | 55117 | 0% | 100% | 1 |
3 | INFLAMMAT P GRP | 55117 | 0% | 100% | 1 |
4 | MED MED SECT ALLERGY ASTHMA IMMUNOL | 55117 | 0% | 100% | 1 |
5 | SACK LER PULM PHARMACOL | 55117 | 0% | 100% | 1 |
6 | UNITA PNEUMOL RIABILITAZIONE P | 55117 | 0% | 100% | 1 |
7 | CLIN DOGS CATS | 27557 | 0% | 50% | 1 |
8 | HEISLER | 27557 | 0% | 50% | 1 |
9 | PHARMACOL PHARMACEUT | 19590 | 1% | 9% | 4 |
10 | BODY MED | 18371 | 0% | 33% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF RESPIRATORY DISEASES | 7564 | 3% | 1% | 14 |
2 | ACTA PHARMACOLOGICA ET TOXICOLOGICA | 4841 | 2% | 1% | 10 |
3 | BRITISH JOURNAL OF PHARMACOLOGY | 3151 | 6% | 0% | 32 |
4 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 3094 | 4% | 0% | 20 |
5 | PULMONARY PHARMACOLOGY & THERAPEUTICS | 3011 | 2% | 1% | 9 |
6 | ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 2937 | 2% | 0% | 11 |
7 | AGENTS AND ACTIONS | 2455 | 2% | 0% | 12 |
8 | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2271 | 4% | 0% | 21 |
9 | AMERICAN REVIEW OF RESPIRATORY DISEASE | 2268 | 3% | 0% | 16 |
10 | BULLETIN OF PHARMACEUTICAL SCIENCES | 1506 | 0% | 1% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FOZARD, JR , HANNON, JP , (2000) SPECIES DIFFERENCES IN ADENOSINE RECEPTOR-MEDIATED BRONCHOCONSTRICTOR RESPONSES.CLINICAL AND EXPERIMENTAL ALLERGY. VOL. 30. ISSUE 9. P. 1213 -1220 | 33 | 72% | 27 |
2 | HOLGATE, ST , (2005) THE IDENTIFICATION OF THE ADENOSINE A(2B) RECEPTOR AS A NOVEL THERAPEUTIC TARGET IN ASTHMA.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 145. ISSUE 8. P. 1009-1015 | 43 | 43% | 64 |
3 | LIVINGSTON, M , HEANEY, LG , ENNIS, M , (2004) ADENOSINE, INFLAMMATION AND ASTHMA - A REVIEW.INFLAMMATION RESEARCH. VOL. 53. ISSUE 5. P. 171-178 | 37 | 47% | 37 |
4 | POLOSA, R , CHURCH, MK , HOLGATE, ST , (1990) THE MODE OF ACTION OF AIRWAY RESPONSES TO ADENOSINE IN ASTHMA.IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. VOL. 10. ISSUE 2. P. 363-372 | 33 | 75% | 2 |
5 | MEADE, CJ , DUMONT, I , WORRALL, L , (2001) WHY DO ASTHMATIC SUBJECTS RESPOND SO STRONGLY TO INHALED ADENOSINE?.LIFE SCIENCES. VOL. 69. ISSUE 11. P. 1225 -1240 | 34 | 42% | 40 |
6 | CRIMI, N , POLOSA, R , MISTRETTA, A , (1993) MECHANISMS OF THE EFFECTOR FUNCTION OF ADENOSINE IN ASTHMA AND RHINITIS.DRUG DEVELOPMENT RESEARCH. VOL. 28. ISSUE 3. P. 322-327 | 25 | 78% | 3 |
7 | HOLGATE, ST , CHURCH, MK , POLOSA, R , (1991) ADENOSINE - A POSITIVE MODULATOR OF AIRWAY INFLAMMATION IN ASTHMA.ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. VOL. 629. ISSUE . P. 227 -236 | 27 | 77% | 0 |
8 | NG, WH , POLOSA, R , CHURCH, MK , (1990) ADENOSINE BRONCHOCONSTRICTION IN ASTHMA - INVESTIGATIONS INTO ITS POSSIBLE MECHANISM OF ACTION.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 30. ISSUE . P. S89-S98 | 27 | 77% | 16 |
9 | CRIMI, N , POLOSA, R , MISTRETTA, A , (1997) PURINE DERIVATIVES IN THE STUDY OF ALLERGIC INFLAMMATION IN RESPIRATORY DISEASES.ALLERGY. VOL. 52. ISSUE . P. 48-54 | 30 | 52% | 5 |
10 | THORNE, JR , BROADLEY, KJ , (1992) ADENOSINE-INDUCED BRONCHOCONSTRICTION OF ISOLATED LUNG AND TRACHEA FROM SENSITIZED GUINEA-PIGS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 106. ISSUE 4. P. 978-985 | 29 | 63% | 14 |
Classes with closest relation at Level 1 |